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Background: There is a paucity of data regarding the impact of adding cilostazol to dual
antiplatelet therapy (DAPT) on the clinical outcomes after percutaneous coronary
intervention for unprotected left main coronary artery (LMCA) disease.
Methods: We evaluated 325 patients who underwent percutaneous coronary intervention
(PCI) with DES for left main coronary artery stenosis  50% from Sejong General
Institute PCI database registry between April 2003 and December 2010. Triple antiplatelet
therapy (TAPT) was defined as the addition of cilostazol for at least 3 months to
conventional DAPT after PCI. Patients who has been taken cilostazol for at least 3 months
1 year after PCI (n21),and had other antiplatelet agents or warfarin (n14) were
excluded. The primary effectiveness endpoint was major adverse cardiac and cerebral
events (MACCE), defined as the composite outcomes of cardiac death, non-fatal
myocardial infarction, ischemic stroke and target lesion revascularization (TLR). The
primary safety endopoints were Thrombolysis In Myocardial Infarction (TIMI) major and
minor bleeding.
Results: Of the 290 total patients, 137 patients received TAPT and 153 patients received
DAPT. TAPT group had higher incidences of male sex and distal bifurcation involvement
requiring 2 stent technique, and tendency of higher incidence of diabetes mellitus
compared to DAPT group. DAPT group included more patients presented with acute
myocardial infarction. During follow-up (median 29.6 months), MACCE occurred in 57
patients (19.6 %); 25 (18.2%) in the TAPT group and 32 (21.3 %) in the DAPT group
(P0.18 by log-rank test). In multivariate analysis, TAPT was not associated with a lower
incidence of MACCE (hazard ratio [HR]: 0.71, 95% confidence interval [CI]: (0.39-1.29)
and of cardiac death, MI or ischemic stroke (HR: 0.66, 95% CI: (0.34-1.29). TIMI major
and minor bleeding occurred at both similar rates. [5.8% (n8) Vs 6.0% (n9), TAPT
Vs DAPT group, P0.99 for TIMI major bleeding, and 16.8% (n23) Vs 18.7% (n28),
TAPT Vs DAPT group, P0.76 for TIMI minor bleeding].
Conclusions: In our registry data, TAPT didn’t either reduce the incidence of MACCE
or increase clinical bleeding after PCI using DES for unprotected LMCA disease.
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Background: Percutaneous coronary intervention (PCI) for unprotected distal left main
lesions (UDLM) is increasing with the improvement in device technology. However, ISR
remains one of the main limitations for PCI. This study aims to determine the predictors
of main branch re-stenosis (MB-ISR) and clarify the optimal PCI strategy for UDLM.
Methods: Between April 2002 and December 2008, 568 consecutive patients with
UDLM following PCI with drug eluting stent (Cypher and TAXUS) implantation were
evaluated.
Results: Overall-ISR during follow-up period (median 1611 days IQR 1157-2021)
occurred in 127/568 patients (22.4%); MB-ISR in 60 (10.6%), SB-ISR in 92 (16.2%) and
both MB/SB-ISR in 25 (4.4%). Multivariable analysis demonstrated that concomitant
calcificated and true bifurcation {adjusted HR 2.548, 95% CI 1.389-4.674; p0.003} and
smaller post-stenting minimal luminal diameter {adjusted HR 0.550, 95% CI 0.331-0.913;
p0.021} were the positive independent predictors of MB-ISR, while full-left main
ostium- cover approach (FCA) {adjusted HR 0.618, 95% CI 0.361-1.058; p0.079}
seemed to be the negative predictor of MB-ISR. Occurrence of MB-ISR following
minicrush-stenting and FCA was the lowest than the other strategy (3.4%). Cardiac-death
were more frequent in patients with MB-ISR versus in patients with no MB-ISR (HR
2.143; p0.04).
Conclusions: Presence of calcificated and true bifurcation and suboptimal expanded
lesion were associated with increasing risk of MB-ISR following UDLM intervention,
while FCA seemed to be associated with the low occurrence of MB-ISR. MB-ISR was
associated with increased risk of subsequent cardiac-death.
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Background: The proliferation of our understanding for LMCA stenosis and the
evolution of contemporary bypass surgery and stent-assisted percutaneous coronary
intervention (PCI) have led to substantial clinical uncertainty regarding the prognostic
impact of LMCA revascularization. We evaluated whether the left main coronary artery
(LMCA) revascularization is associated with the incremental risk of adverse clinical
outcomes in multivessel coronary artery disease patients.
Methods: We performed a pooled analysis of 2898 multivessel disease patients with or
without significant LMCA stenosis (777 patients and 2121 patients, respectively) from
ASAN-MAIN and ASAN-Multivessel Registry; 1773 patients with PCI and 1125 patients
were treated with bypass surgery. Primary endpoint was the composite of death,
myocardial infarction or stroke.
Results: LMCA stenosis was associated with higher EuroScore (3.22.1 vs. 2.92.0,
p0.001) and more complex non-LMCA coronary artery disease assessed by Syntax
score (21.711.0 vs. 18.67.8, p0.001). A 5-year incidence of death, myocardial
infarction or stroke was significantly higher in patients with LMCA stenosis than those
without LMCA stenosis (15.4% vs. 11.3%, p0.026). However, after adjustment of
comorbidities and anatomical complexity by using IPTW, LMCA revascularization was
not associated with the increase of the risk of the composite of death, myocardial
infarction or stroke (Hazard ratio 1.11, 95% confidence interval 0.86-1.43, p0.42).
Subgroup analysis for 2 vessel disease and 3 vessel disease showed the similar trends.
Conclusions: Contemporary revascularization treatment for the significant LMCA
stenosis conducted by experienced operators did not increase the risk of adverse clinical
outcomes. However, physician should carefully evaluate and manage the comorbidities
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Background: Nicorandil, an ATP sensitive potassium-channel opener, may reduce the
incidence of microvascular dysfunction after percutaneous coronary intervention (PCI) by
dilating coronary resistance vessels. The aim of this study was to evaluate a coronary
pressure wire-derived Index of Microcirculatory Resistance for assessing the microvas-
culature in patients with stable angina pectoris undergoing PCI.
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